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SUMMARY
In Malaysia, transbronchial needle aspiration (TBNA) is a
relatively new procedure performed only in a handful of
respiratory centres.  We reviewed TBNA of mediastinal lymph
node performed in Hospital Tengku Ampuan Afzan (HTAA) to
determine the yield and its complications.   Data was
retrieved from endoscopy databases and patients’ records,
CT thorax images and all cytological and histological slides
were reviewed.  Twenty-five patients had TBNA performed.
TBNA was positive in 15 patients (60%).  Overall, 80% had
confirmed malignancy after bronchoscopy.  Only four
patients had documented bleeding after TBNA and in two of
them, bleeding stopped spontaneously and another two
patients required diluted adrenaline to stop the bleed. No
mortality was reported from this procedure.  Hence, TBNA is
a safe procedure.  
KEY WORDS:
Transbronchial needle aspiration, Yield, Bronchoscopy, Lung
cancer
INTRODUCTION
Transbronchial needle aspiration (TBNA) of mediastinal
lymph node using flexible bronchoscope was first described
in 1983 1.  Since then, it has gained popularity in Europe and
America due to its less invasive fashion as compared to
mediastinoscopy or open surgery. It is particularly useful to
establish histological diagnosis in patients with peripheral
lung lesion associated with mediastinal lymphadenopathy
and staging of lung cancer.  Other than sampling of the
lymph node, transbronchial needle aspiration is also useful in
diagnosis and/or drainage of mediastinal cyst or mediastinal
abscesses. 
In Malaysia, there are only a handful of centres performing
this procedure.  This is probably due to lack of training
facilities and data on the usefulness and safety of this
procedure in Malaysia (Personal communication with chest
physicians in the country). Therefore, we reviewed all TBNA
of mediastinal lymph node performed in Hospital Tengku
Ampuan Afzan (HTAA) since 2003 to determine the yield and
to find out if there were serious complications and mortality
related to this procedure. 
MATERIALS AND METHODS
All TBNA performed in HTAA from January 2003 to
September 2007 were retrieved from endoscopy databases and
patients’ names and registration numbers were recorded.
Then patients’ records, CT thorax images and all cytological
and histological slides were reviewed. The histological slides
were reviewed by two pathologists in HTAA.  CT thorax
images were reviewed and the maximum sizes of mediastinal
lymph nodes on which TBNA were performed were obtained. 
All patients had CT thorax before the procedure.  Preparation
of patients was similar to bronchoscopy.  Coagulation profile
was not a routine unless patients had a history of bleeding
diathesis.  Consent was taken before the procedure and the
patients were sedated with intravenous midazolam 2-10mg.
Nostril, posterior pharynx, vocal cord, primary carina and left
and right main bronchi were anaesthetised with 10-20 ml of
0.1% lignocaine.  After visualizing all bronchi and performing
bronchio-alveolar lavage (BAL), biospy, brushing or
transbronchial lung biopsy (TBLB) if indicated, lignocaine
0.1% was used to anaesthetize the site of puncture. The TBNA
needles used were the 22-gauge and 19-gauge needles.  The
TBNA needle was advanced to penetrate through the
intercartilaginous space.  Then suction was applied with a 20-
ml syringe and the needle was moved in and out by 3 to 4
mm.  The specimen was then directly placed onto a few
slides, and immediately smeared and fixed with 95% alcohol.
Occasionally, cytology technician was called to perform rapid
on-site cytologic evaluation (ROSE) during TBNA if they were
available. 
Statistical Analysis 
The data was analyzed using Statistical Package for the Social
Sciences (SPSS) version 12 software package.  Categorical
variables were tested using Chi-square test. Significance was
taken at 0.05. 
RESULTS
All TBNA performed in HTAA from January 2003 to
September 2007 were retrieved from endoscopy databases and
patients’ names and registration numbers were recorded.
Then patients’ records, CT thorax images and all cytological
and histological slides were reviewed. The histological slides
were reviewed by two pathologists in HTAA.  CT thorax
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images were reviewed and the maximum sizes of mediastinal
lymph nodes on which TBNA were performed were obtained. 
All patients had CT thorax before the procedure.  Preparation
of patients was similar to bronchoscopy.  Coagulation profile
was not a routine unless patients had a history of bleeding
diathesis.  Consent was taken before the procedure and the
patients were sedated with intravenous midazolam 2-10mg.
Nostril, posterior pharynx, vocal cord, primary carina and left
and right main bronchi were anaesthetised with 10-20 ml of
0.1% lignocaine.  After visualizing all bronchi and performing
bronchio-alveolar lavage (BAL), biospy, brushing or
transbronchial lung biopsy (TBLB) if indicated, lignocaine
0.1% was used to anaesthetize the site of puncture. The TBNA
needles used were the 22-gauge and 19-gauge needles.  The
TBNA needle was advanced to penetrate through the
intercartilaginous space.  Then suction was applied with a 20-
ml syringe and the needle was moved in and out by 3 to 4
mm.  The specimen was then directly placed onto a few
slides, and immediately smeared and fixed with 95% alcohol.
Occasionally, cytology technician was called to perform rapid
on-site cytologic evaluation (ROSE) during TBNA if they were
available. 
Statistical Analysis 
The data was analyzed using Statistical Package for the Social
Sciences (SPSS) version 12 software package.  Categorical
variables were tested using Chi-square test. Significance was
taken at 0.05. 
DISCUSSION
Lung cancer was already the most prevalent malignant
neoplasm three decades ago2.  As medical practitioners, we
encounter this sinister disease at different stages.   Some of us
detect the disease early, whereas others palliate the disease.
Nevertheless, many physicians will agree that early diagnosis
and staging play important roles in determining appropriate
treatment and thus, influence the prognosis of this disease.
Transbronchial needle aspiration, which was first developed
by Schieppati 3, and later used with the fiberoptic
bronchoscope 4, is now beginning to gain acceptance as an
essential tool to stage the extent of mediastinal lymph nodes
involvement in malignant disease.
The positive yield obtained in our study was 60%, whereas
results from other studies have demonstrated a positive yield
of 45% to 96% 1,5,6.  The varied positive yield obtained from
different studies suggests that transbronchial needle
aspiration was not only operator-dependent 7, but also
depended on other factors to achieve high yield.  These
factors are likely to include the type of needle, technique,
tomographic evaluation, tissue preparation, tissue
interpretation, nodal site and size 8. 
Dasgupta A et al 6 reported that when TBNA was used in
combination with conventional diagnostic procedures, a
significantly higher diagnostic yield was achieved as
compared to conventional diagnostic procedures only. In the
same study, TBNA alone achieved a diagnostic yield of 96%
whereas conventional diagnostic procedures i.e. bronchial
washing, bronchial brushing and endobronchial forceps
biopsy, achieved diagnostic yields of 22%, 48% and 43%
respectively.   Two other studies 9,10 also showed an increased
yield with TBNA when used in addition to conventional
diagnostic techniques: Shure and Fedullo 9 demonstrated a
yield of 97% when the combination of TBNA, endobronchial
forceps biopsy, brushing and washing were used, and
Caglayan B et al 10 obtained results with a yield of 91% using
TBNA plus conventional diagnostic techniques.  In our study,
TBNA was positive in 50% of ten patients who had negative
bronchial washing, bronchial brushing, endobronchial
forceps biopsy and transbronchial lung biopsy, which meant
that TBNA was exclusively diagnostic in 20% of the total 25
patients studied.   This figure is comparable to results from
the study by Dasgupta A et al 6, which showed that TBNA was
exclusively diagnostic in 20% of patients.  In a study of 228
patients, Kvale et al 11 found that bronchial washings did not
add significant diagnostic yield when forceps biopsy and
bronchial brushing were simultaneously performed.  In our
study, only three patients had positive BAL and all three of
them had positive TBNA (including two of them who had
positive brushing and one had positive biopsy).   In view of
these results, there appears to be no advantage in performing
bronchial washing if TBNA or other sampling procedures i.e.
bronchial brushing and endobronchial forceps biopsy, are
conducted simultaneously.  With the addition of TBNA to
other sampling procedures, a high diagnostic yield can be
achieved.
Schenk et al5 reported that diagnostic yield varied with
aspirates taken from different anatomical sites; parabronchial
aspirates, 39%, carinal aspirates, 54% and paratracheal
aspirates, 57%.  Similarly, Ceron et al 12 reported that
diagnostic aspirates from right paratracheal nodal station,
anterior carina and aorto-pulmonary window were 74%, 63%
and 64% respectively. We obtained transbronchial needle
aspirates from subcarinal, paratracheal and hilar nodal
stations, but did not separate the specimens according to
different nodal stations.   However, several studies 13-16 have
Procedure Total No. of procedure % of procedures No of positive Yield (n/NX100%)
performed (N) performed in all patients result (n)
TBNA 25 100 15 60
BAL 17 68 3 18
Brushing 16 64 9 56
Endobronchial biopsy 10 40 4 40
TBLB 9 36 4 44
Subcutaneous lymph node biopsy 4 16 3 75
TBNA: Transbronchial needle aspiration 
BAL : Bronchio-alveolar lavage 
TBLB : transbronchial lung biopsy 
Table I: Diagnostic Yield of Various Bronchoscopy Procedures 
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shown that disease involving subcarinal nodes and multiple
areas of nodal involvement carry a poor prognosis. This
suggests that separation of the transbronchial needle
aspiration specimens according to different nodal stations
may be helpful in staging lung cancer and determining
appropriate subsequent treatment. 
Although the result was not statistical significant, TBNA from
a lymph node with a size of 2 cm or more had a diagnostic
yield of 75%, compared to 50% when a lymph node with a
size of less than 2 cm was aspirated.  However, Ceron et al 12
from their study of 827 transbronchial needle aspirations in
732 patients proved that diagnostic yield had a linear relation
to lymph node size: 62%, 75% and 79% where the short axis
was <1cm, 1 to 2cm and >2cm respectively.  The small sample
size in our study was the likely cause of negative correlation.
One other factor that could have influenced the diagnostic
yield of our study was the type of needle used. We have used
the 22-gauge needle in all except two patients, in whom the
19-gauge needle was used. Although transbronchial needle
aspiration using the 19-gauge needle was shown by Ceron et
al 12 to improve diagnostic yield, achieving 80% compared to
66% when the 22-gauge needle was used, the study did not
employ 19-gauge needle on small targets (<1 cm in diameter).
In the subset of patients with nodal targets >2 cm, they
reported similar diagnostic yield of the two needles.  This
suggests that in patients with smaller lymph node size (<2
cm), the 19-gauge needle should be employed, whereas in
patients with larger lymph node size (>2 cm), either the 19-
gauge or the 22-gauge needle can be used. 
Tissue preparation and interpretation are important factors to
consider for achieving a high TBNA diagnostic yield.  Oki M
et al 17 reported that by using the 19-gauge needle, a greater
frequency of TBNA specimens with non-specific diagnoses
were small in size (>0 and <1 mm2), fewer specimens with
non-specific diagnoses were large in size (>2 mm2).  In other
words, the specimen of larger size appears to increase
diagnostic yield.   With regards to sample preparation, two
widely practiced methods were compared prospectively by
Diacon AH et al 18 to determine which has a higher yield.  In
the first method, the specimens were flushed into a container
and transported as a fluid suspension to the laboratory, where
they were processed further (called the fluid technique), while
in the second method, the specimen was directly placed onto
a slide, and immediately smeared and spray-fixed (called the
direct technique).  They reported that the direct technique
had a better yield overall than the fluid technique (p<0.01).
The study used the patients as their own control subjects,
which virtually eliminated all other variables except
preparation method. The direct technique is superior because
the fluid technique may have resulted in cell loss during
transportation and laboratory preparation.  By obtaining
multiple TBNA samples, diagnostic yield can be increased.
However, this practice may also increase cost, duration and
risk of bronchoscopy.   Rapid on-site cytologic evaluation
(ROSE) during TBNA was reported by Baram D et al 19 to be
accurate and allows deferral of additional biopsy without
compromising yield.  They reported that ROSE has a
sensitivity of 88% and specificity of 94% in predicting final
TBNA diagnosis of malignancy.  Although we had a cytologist
available to evaluate our TBNA samples during bronchoscopy,
this data was not collected during the course of our study for
analysis.  Based on these reports 17-19, TBNA during
bronchoscopy should ideally be carried out with ROSE, the
specimen should be taken using the 19-gauge needle to
obtain a larger specimen, and the direct technique should be
used to prepare the specimen for further examination.  
TBNA is a safe procedure.  Although bleeding, bacteraemia,
pneumothorax and pneumomediastinum are known
complications, Dasgupta et al 6 reported only one out of 55
patients who had minor bleeding following TBNA, whereas
other studies 5,7,12 reported that no complications of
significance were encountered.  In our study, only four of the
25 patients had bleeding following TBNA and in two of them,
bleeding arrested spontaneously.  Two other patients required
diluted adrenaline to stop the bleeding.  Therefore,
bronchoscopists should consider TBNA as one of the routine
sampling procedures besides bronchial brushing and
endobronchial forceps biopsy, as serious complications
following TBNA are rare.
Since it was adapted for use with flexible bronchoscopy,
transbronchial needle aspiration is a procedure that
continues to undergo improvisation to achieve higher
diagnostic yield.  These include guidance techniques, such as
CT-fluoroscopy guided TBNA 20 and endobronchial
ultrasound-guided TBNA 21.  As the trend moves towards
minimally invasive techniques, TBNA is a valuable tool to
diagnose lesions in the mediastinum and lung; without
subjecting the patient to surgery.  As techniques advance with
time, so must our skills for surely, the tool is only as good as
its operator.
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